BioCentury
ARTICLE | Company News

GlaxoSmithKline, The Wellcome Trust, University of Dundee infectious news

March 12, 2012 7:00 AM UTC

The university and GlaxoSmithKline received £8.6 million ($13.6 million) from the Wellcome Trust to develop treatments for Chagas disease, leishmaniasis and African sleeping sickness. The university's...